[{"Assets_0_Q1_USD":249857000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":9407000.0,"NetIncomeLoss_1_Q1_USD":8106000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":42446000.0,"StockholdersEquity_0_Q1_USD":178642000.0,"EarningsPerShareBasic_1_Q1_USD":0.19,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20181231","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20190211"}]